Infliximab Dose Doubling in Patients With Ulcerative ColitisInfliximab Dose Doubling in Patients With Ulcerative Colitis
What does the latest research tell us about the efficacy and safety of infliximab dose doubling in ulcerative colitis patients with a loss of response to infliximab? Alimentary Pharmacology & Therapeutics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
More News: Drugs & Pharmacology | Gastroenterology | Health | Inflammatory Bowel Disease | Remicade | Ulcerative Colitis